Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,976,146
+$496,326 QoQ
Shares Held
11,827
+3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
#1,658
of 4,153 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 63%
Shared 37%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Corsicana & Co. holds $7,494,081 across 12 Drug Manufacturers - General names. ABBV ranks #2 (39.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,904 | $3,785,168 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
11,827 | $2,976,146 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,665 | $342,452 | |
| 4 | LLY |
ELI LILLY & Co
|
228 | $273,470 | |
| 5 | PFE |
Pfizer Inc
|
2,615 | $62,969 | |
| 6 | AZN |
Astrazeneca PLC
|
100 | $18,962 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
310 | $17,862 | |
| 8 | AMGN |
Amgen Inc
|
16 | $5,793 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,976,146 | 11,827 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,479,820 | 11,402 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,597,245 | 11,367 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,657,384 | 11,477 | Shares | Sole | 2025-10-10 | |
| 2022-09-30 | $1,715,874 | 12,785 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,894,589 | 12,370 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,933,648 | 11,928 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $1,539,904 | 11,373 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $1,206,849 | 11,188 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $209,848 | 1,863 | Shares | Sole | 2021-07-01 | |
| No filing history on record for this holder in this stock. | ||||||